Studies will examine the signaling mechanisms and function of the 75 kDa neurotrophin receptor, p75/NTR and several structural homologs of P75/NTR. Experiments will test the hypothesis that neurotrophins activate NF-kappaB by a signaling pathway involving p75/NTR- dependent activation of the small G protein Rac, which stimulates superoxide production. A putative novel ligand for p75/NTR will be cloned and functionally characterized. The possible involvement of t he protease TACE in release of a soluble p75/NTR ectodomain from the cell surface will be assessed, by comparing p75/NTR processing in wildtype mouse fibroblasts and fibroblasts from mice lacking the TACE gene. Two structural homologs of p75/NTR will be characterized, expressing these proteins by transfection of various mammalian cell lines with suitable expression vectors. Homolog NRH1 will be expressed in CHO cells and assessed for ability to bind neurotrophins. The capacity of NRH1- mediated signaling to activate NF-kappaB and/or Rac will be assessed,, and the capacity of NRH1 to act as a subunit of a heteromeric p75/NTR receptor complex will be assessed, and the capacity of NRH1 to act as a subunit of a heteromeric p75/NTR receptor complex will be assessed. The possible existence of a mammalian homolog of Xenopus NRH1 will be sought by cDNA library screening. NRH2 encodes a protein resembling the product of the putative TACE-mediated cleavage of P75/NTR. The capacity of NRH2 to act as a dominant negative inhibitor of p75rt/NTR signaling will be assessed. Functions of NRH2 (and NRH1 if present in mice) will be assessed by gene-targeted mutations in mice. The possible existence of a NRH2 splice variant possessing a p75/NTR- like ligand binding will be sought by cDNA library screening. The patterns of developmental expression of P75/NTR, NRH1 and NRH2 will be examined in Xenopus and mice, to assess whether the opportunity for functional interactions exist.

Agency
National Institute of Health (NIH)
Institute
National Institute of Neurological Disorders and Stroke (NINDS)
Type
Research Project (R01)
Project #
5R01NS033200-10
Application #
6711096
Study Section
Special Emphasis Panel (ZRG1-MDCN-1 (02))
Program Officer
Mamounas, Laura
Project Start
1995-01-01
Project End
2005-02-28
Budget Start
2004-03-01
Budget End
2005-02-28
Support Year
10
Fiscal Year
2004
Total Cost
$339,192
Indirect Cost
Name
University of Washington
Department
Physiology
Type
Schools of Medicine
DUNS #
605799469
City
Seattle
State
WA
Country
United States
Zip Code
98195
Hatch, Nan E; Hudson, Mark; Seto, Marianne L et al. (2006) Intracellular retention, degradation, and signaling of glycosylation-deficient FGFR2 and craniosynostosis syndrome-associated FGFR2C278F. J Biol Chem 281:27292-305
Kanning, Kevin C; Hudson, Mark; Amieux, Paul S et al. (2003) Proteolytic processing of the p75 neurotrophin receptor and two homologs generates C-terminal fragments with signaling capability. J Neurosci 23:5425-36
Burke, Melanie A; Bothwell, Mark (2003) p75 neurotrophin receptor mediates neurotrophin activation of NF-kappa B and induction of iNOS expression in P19 neurons. J Neurobiol 55:191-203
Iwamoto, Satori; Burrows, Robert C; Kalina, Robert E et al. (2002) Immunophenotypic differences between uveal and cutaneous melanomas. Arch Ophthalmol 120:466-70
Iwamoto, Satori; Burrows, Robert C; Grossniklaus, Hans E et al. (2002) Immunophenotype of conjunctival melanomas: comparisons with uveal and cutaneous melanomas. Arch Ophthalmol 120:1625-9
Hutson, L D; Bothwell, M (2001) Expression and function of Xenopus laevis p75(NTR) suggest evolution of developmental regulatory mechanisms. J Neurobiol 49:79-98
Iwamoto, S; Burrows, R C; Agoff, S N et al. (2001) The p75 neurotrophin receptor, relative to other Schwann cell and melanoma markers, is abundantly Expressed in spindled melanomas. Am J Dermatopathol 23:288-94
Gunther, E C; von Bartheld, C S; Goodman, L J et al. (2000) The G-protein inhibitor, pertussis toxin, inhibits the secretion of brain-derived neurotrophic factor. Neuroscience 100:569-79
Yuen, E C; Gunther, E C; Bothwell, M (2000) Nitric oxide activation of TrkB through peroxynitrite. Neuroreport 11:3593-7
Iwamoto, S; Burrows, R C; Born, D E et al. (2000) The application of direct immunofluorescence to intraoperative neurosurgical diagnosis. Biomol Eng 17:17-22